Home » Topics » Medical technology » Diagnostics

Diagnostics
RSS

Nymox's urinary test for Alzheimer's disease successfully completes initial trials

Oct. 22, 1997

Eisai: Annual Report 1997

Oct. 22, 1997

Matritech files for clearance of new colon cancer test with FDA

Oct. 21, 1997

PMA supplement submitted for Digene's HPV diagnostic

Oct. 16, 1997

Quidel and Glaxo Wellcome sign agreement for diagnostic tests

Oct. 10, 1997

ImmunoCyt introduced in Canada and Europe

Oct. 8, 1997

Breast cancer imaging agent approved in Canada

Oct. 8, 1997

Potential early warning sign for heart transplant rejection

Oct. 8, 1997

ChemTrak reacquires rights to H. pylori test

Oct. 3, 1997

Alliance and Schering AG sign agreement for Imagent US

Sep. 25, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...